Just last week, Tesla laid off yet another round of workers. This time, however, Tesla gutted an entire team. Around 500 ...
Some experts say the recommended doses for drugs like sotorasib are too high, and they are advocating for a change in how cancer drugs are dosed. They want to do away with the concept of the maximum ...
Amgen and Johnson & Johnson earned billions on the trio of anemia drugs Epogen, Procrit and Aranesp since their introduction in 1989. But over time, an understanding of their risks has grown, as ...
Amgen (NASDAQ: AMGN) is one of the top drugmakers in the world, with a market value north of $140 billion. The company has been expanding its business via acquisitions in recent years as it looks ...
The move comes after the Elon Musk-led automaker disbanded its EV charging department following Tesla’s announcement last ...
Walking Fish Therapeutics has closed after a lead investor backed out of a critical series B round. CEO Rusty Williams, M.D., Ph.D., said in an interview with Fierce Biotech that the company was on ...
April 4 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor U.S. sales of its biosimilar version of AbbVie’s blockbuster arthritis treatment Humira.
Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...
Amgen's acquisition of Horizon Therapeutics has made it a major player in the rare disease space, with potential for long-term shareholder return. The company has key pipeline milestones in 2024 ...
Researchers including the team at Columbia and drugmakers are trying to solve the biggest problem in the weight-loss industry ...
(Adds Boehringer comment in paragraphs 4 and 5 of April 4 story) By Patrick Wingrove April 5 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to ...